Viracta Therapeutics, Inc.
VIRX
Revenue
120.00k
▼-117.00k▼-49.37%
24 Months ChangeAssets
31.32M
▼-10.01M▼-24.22%
3 Months ChangeLiabilities
28.65M
▼-1.60M▼-5.30%
3 Months ChangeFree Cash Flow
-11.46M
▼-11.46M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0000950170-24-096982
2024-08-14
Form 8-K
ID: 0000950170-24-096648
2024-07-29
Form 8-K
ID: 0000950170-24-087020
2024-06-20
Form 8-K
ID: 0001193125-24-164449
2024-05-31
Form 8-K
ID: 0000950170-24-067393
2024-05-14
Form 8-K
ID: 0000950170-24-059668
2024-05-09
Form 10-Q
ID: 0000950170-24-057250
2024-05-09
Form 8-K
ID: 0000950170-24-057130
2024-04-09
Form 8-K
ID: 0000950170-24-043014
2024-03-20
Form 8-K
ID: 0000950170-24-034230